VMP 3546911000001102

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Generic Migraleve Pink tablets
BNF code 0407041A0AAAGAG
Virtual Therapeutic Moiety Paracetamol + Codeine + Buclizine
Basis of preferred name Other
Prescribing status Never Valid To Prescribe As A VMP
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Buclizine hydrochloride
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 6.250
Strength value numerator unit mg
Virtual Product Ingredient
Ingredient Paracetamol
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 500.000
Strength value numerator unit mg
Virtual Product Ingredient
Ingredient Codeine phosphate
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 8.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category Schedule 5 (CD Inv)
Date of applicability 27 Oct 2003
Previous Controlled Drug information No Controlled Drug Status
Actual Medicinal Products
Migraleve Pink tablets (McNeil Products Ltd)
Virtual Medicinal Product Packs
Generic Migraleve Pink tablets 12 tablet
Generic Migraleve Pink tablets 16 tablet
Generic Migraleve Pink tablets 24 tablet
Generic Migraleve Pink tablets 32 tablet
Generic Migraleve Pink tablets 48 tablet
Generic Migraleve Pink tablets 8 tablet

dm+d data retrieved from TRUD: release NHSBSA_12.2.0_20241216000001, imported on 17th December 2024 at 04:01:15.

Feedback